High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model.

Slides:

Advertisements

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Advertisements

Grace Younes, M.D., Togas Tulandi, M.D., M.H.C.M.

Clinically significant and sustained weight loss is achievable in obese women with polycystic ovary syndrome followed in a regular medical practice Lysanne.

Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D.

Clinical outcome of non–hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome Michel De Vos,

A prediction model for selecting patients undergoing in vitro fertilization for elective single embryo transfer Claudine C Hunault, M.D., Marinus J.C.

Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis Ouijdane Hamdine,

Risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systematic review and a meta-analysis Konstantinos A. Toulis, M.D.,

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of blastocyst-stage versus cleavage-stage embryos generated through.

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis Anuja Dokras, M.D., Ph.D., Shari.

Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D

Thyroid antibodies and gestational diabetes mellitus: a meta-analysis

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Patient-tailored ovarian stimulation for in vitro fertilization

Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome Anuja Dokras, M.D., Ph.D., Shailly Saini,

Does polycystic ovary syndrome affect cognition

Fertility and Sterility Volume 89, Issue 3, Pages (March 2008)

The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.

Trends in clinical reproductive medicine research: 10 years of growth

Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach Fatemeh Bazarganipour,

The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility Alexander M. Quaas, M.D.,

Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis

Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Emanuela Stochino-Loi,

Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.

Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis

Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study

Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort.

Progesterone luteal support after ovulation induction and intrauterine insemination: a systematic review and meta-analysis Micah J. Hill, D.O., Brian.

Fertility and Sterility Volume 98, Issue 5, Pages (November 2012)

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study Li Wei, Ph.D., Thomas MacDonald, M.D.,

Roger Hart, M. D. , Dorota A. Doherty, Ph. D. , Trevor Mori, Ph. D

Improving the Reporting of Clinical Trials of Infertility Treatments (IMPRINT): modifying the CONSORT statement Fertility and Sterility Volume 102,

Interaction of apolipoprotein E gene polymorphisms on miscarriage risk in black and white American women Silvia Gamundi-Segura, M.Sc., Elena Torres-Perez,

Impact of oocyte donation on perinatal outcome in twin pregnancies

Ovulation induction in women with polycystic ovary syndrome

Pretreatment with estrogen does not affect IVF-ICSI cycle outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomized.

Cumulative newborn rates increase with the total number of transferred embryos according to an analysis of 15,792 ovum donation cycles Nicolás Garrido,

Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis Katherine A. Green,

Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision- analytic model Lobke M. Moolenaar, M.D., Frank J.M. Broekmans,

Marianne de Bennetot, M. D. , Benoît Rabischong, M. D. , Ph. D

Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis.

The impact of chronic endometritis on reproductive outcome

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in.

Metformin treatment before and during in vitro fertilization or intracytoplasmic sperm injection in women with polycystic ovary syndrome: summary of a.

Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D. Fertility and Sterility

Luteal support with intravaginal progesterone increases clinical pregnancy rates in women with polycystic ovary syndrome using letrozole for ovulation.

Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial Antoni J. Duleba, M.D.,

Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women.

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.

Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D.

Prospective, randomized comparison between raloxifene and clomiphene citrate for ovulation induction in polycystic ovary syndrome Ernesto de Paula Guedes.

A randomized clinical trial to determine optimal infertility treatment in older couples: the Forty and Over Treatment Trial (FORT-T) Marlene B. Goldman,

Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic.

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,

Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction and achievement of pregnancy in 154 women with.

Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics.

Childhood tumor risk after treatment with ovulation-stimulating drugs

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study Xiaobin Wang, M.D., Changzhong Chen, M.D., Lihua.

Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk? Nadine M.P. Daan, M.D., Yvonne V.

A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility

Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility:

Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis

Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity?

The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review.

Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment Daniel Bodri, M.D., M.Sc.,

Presentation transcript:

High singleton live birth rate confirmed after ovulation induction in women with anovulatory polycystic ovary syndrome: validation of a prediction model for clinical practice Susanne M. Veltman-Verhulst, M.D., Bart C.J.M. Fauser, M.D., Ph.D., Marinus J. Eijkemans, M.Sc., Ph.D. Fertility and Sterility Volume 98, Issue 3, Pages 761-768.e1 (September 2012) DOI: 10.1016/j.fertnstert.2012.04.027 Copyright © 2012 Terms and Conditions

Figure 1 Cumulative pregnancy rate resulting in singleton live birth of the current validation population and the previously reported population of the initial prediction model, calculated by Kaplan-Meier method. Dotted lines represent the 95% CI for the current validation population. Fertility and Sterility 2012 98, 761-768.e1DOI: (10.1016/j.fertnstert.2012.04.027) Copyright © 2012 Terms and Conditions

Figure 2 Flow chart of treatment course of women starting CC treatment. Women were censored when not pregnant at discontinuation of follow-up (e.g., still undergoing fertility treatment at September 1, 2011, premature drop out of fertility treatment, or drop out of conventional treatment program). Twin pregnancies were censored before the treatment cycle resulting in pregnancy. Fertility and Sterility 2012 98, 761-768.e1DOI: (10.1016/j.fertnstert.2012.04.027) Copyright © 2012 Terms and Conditions

Supplemental Figure 1 Calibration plot of association between the predicted chances (in quintiles) and the observed chance of a singleton live birth. (A) Calibration plot of first model. (B) Calibration plot of second model. Fertility and Sterility 2012 98, 761-768.e1DOI: (10.1016/j.fertnstert.2012.04.027) Copyright © 2012 Terms and Conditions